Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data & AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma & Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / App Notes / 2020 / Using Self-Aware Agilent InfinityLab LC/MSD iQ to Measure Trace-Level Impurities in a Brand Versus Generic Medication

Using Self-Aware Agilent InfinityLab LC/MSD iQ to Measure Trace-Level Impurities in a Brand Versus Generic Medication

01/22/2020

Share

Featured Image

This study presents a method for comparison of related impurities in a brand and a generic over-the-counter (OTC) acetaminophen drug. The workflow comprised an Agilent InfinityLab liquid chromatography/mass selective detector (LC/MSD iQ) and an Agilent 1290 Infinity II LC. The study identified impurities at concentrations lower than can be reliably detected by UV.

Most OTC pharmaceutical drugs are available as a generic form developed from a brand name product, and do not require a prescription for purchase. These generic products are sold by different manufacturers to help spur competition, and potentially lower prices making the drug more affordable. Generic OTC drugs manufacturers must meet the same quality attributes such as strength, purity, stability, and the limits for related impurities as determined by the USFDA for approved brand name drugs.1 Generic drug manufacturers must be able to characterize their product and its impurities, typically with HPLC and UV detection. Adding a mass selective detector can significantly reduce the analysis time of typical USP or EP methods2 since coeluting components can be unambiguously determined by the mass of target compounds.

This study shows the comparison of related impurities in a brand versus generic OTC drug of acetaminophen. Impurities were screened using an InfinityLab LC/MSD iQ and, 1290 Infinity II LC. The LC/MSD iQ, based on single quadrupole technology, is a robust detection system designed to be easy to use and reliable. It is an intuitive instrument that requires minimal user training. It can handle high LC flow rates, and automatically optimizes MS parameters to provide optimal results. The use of mass determination ensures unambiguous detection of active pharmaceutical ingredients (APIs), their related impurities, and, more importantly, any unknown or unexpected impurities. Chromatographers can easily incorporate the LC/MSD iQ as a new module in their existing LC stack. It is specifically designed to be easily integrated into the Agilent 1260 Infinity II LC, 1290 Infinity II LC, or even older LCs with a space-design that plugs into the same power outlets as the LC modules. The HPLC stack, including the MS and vacuum pump, can be stored on the Agilent InfinityLab Flex Bench MS, freeing bench space, and allowing the entire system to be relocated swiftly and safely.

>> Download the full Application Note as PDF

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Detection of residual pesticides on fruits and vegetables using Portability™ miniature mass spectrometer
Detection of residual pesticides on fruits and vegetables using Portability™ miniature mass spectrometer

June 9, 2020

Mass spectrometry can be now deployed for onsite pesticide screening in real time...

Routine monitoring of airborne VOCs using TD–GC×GC–TOF MS/FID
Routine monitoring of airborne VOCs using TD–GC×GC–TOF MS/FID

January 15, 2020

The identification and quantitation of volatile organic pollutants in air can be challenging, largely because of the complexity of the samples...

Quantifying trace odorants in water by GC–MS with trap-based preconcentration
Quantifying trace odorants in water by GC–MS with trap-based preconcentration

January 20, 2020

Assessing SPME and high‑capacity sorptive extracti...

Using Self-Aware Agilent InfinityLab LC/MSD iQ to Measure Trace-Level Impurities in a Brand Versus Generic Medication
Using Self-Aware Agilent InfinityLab LC/MSD iQ to Measure Trace-Level Impurities in a Brand Versus Generic Medication

January 22, 2020

This study presents a method for comparison of related impurities in a brand and a generic over-the-counter (OTC) acetaminophen drug...

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.